KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Short-Term Debt issuances (2018 - 2020)

Historic Short-Term Debt issuances for Cme (CME) over the last 4 years, with Q2 2020 value amounting to -$100.0 million.

  • Cme's Short-Term Debt issuances rose 5511.67% to -$100.0 million in Q2 2020 from the same period last year, while for Mar 2021 it was -$100.0 million, marking a year-over-year increase of 8683.17%. This contributed to the annual value of -$304.6 million for FY2020, which is 22929.73% down from last year.
  • As of Q2 2020, Cme's Short-Term Debt issuances stood at -$100.0 million, which was up 5511.67% from -$204.6 million recorded in Q1 2020.
  • In the past 5 years, Cme's Short-Term Debt issuances ranged from a high of $462.3 million in Q1 2019 and a low of -$222.8 million during Q2 2019
  • In the last 3 years, Cme's Short-Term Debt issuances had a median value of -$131.4 million in 2019 and averaged -$1.5 million.
  • Over the last 5 years, Cme's Short-Term Debt issuances had its largest YoY gain of 5511.67% in 2020, and its largest YoY loss of 14425.7% in 2020.
  • Quarter analysis of 3 years shows Cme's Short-Term Debt issuances stood at $386.9 million in 2018, then crashed by 133.96% to -$131.4 million in 2019, then rose by 23.9% to -$100.0 million in 2020.
  • Its Short-Term Debt issuances was -$100.0 million in Q2 2020, compared to -$204.6 million in Q1 2020 and -$131.4 million in Q4 2019.